| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |